Value of pharmaceutical gross-to-net reduction in the U.S. 2012-2018

This statistic shows the total value of pharmaceutical manufacturers gross-to-net reductions on medications in the United States from 2012 to 2018, in billion U.S. dollars. In 2018, rebates and discounts provided by manufacturers totaled some 166 billion dollars.

Total value of pharmaceutical gross-to-net reductions in the U.S. from 2012 to 2018

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

July 2019

Region

United States

Survey time period

2012 to 2018

Supplementary notes

"Gross-to-net reductions are rebates, off-invoice discounts, copay assistance, price concessions, and other reductions like distribution fees, product returns, the 340B Drug Pricing Program, and more."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.